# Salsalate in Patients Mild to Moderate Alzheimer's Disease

> **NCT03277573** · PHASE1 · COMPLETED · sponsor: **Adam Boxer** · enrollment: 40 (actual)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** Salsalate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03277573
- **Lead sponsor:** Adam Boxer
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-21
- **Primary completion:** 2022-02-04
- **Final completion:** 2023-04-10
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2025-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03277573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03277573, "Salsalate in Patients Mild to Moderate Alzheimer's Disease". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03277573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*